Protocols
1 protocol(s) meet the specified criteria
Drug: VECTIBIX
Protocol No.	Title	Status
LCCC1632	Phase II Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal Adenocarcinoma	Open